
The Hidden Risks of Fat Loss Drugs | Sally O'Neil
Notas del episodio
Defining Moments is a short-form series that pulls out the most important insight or turning point from each long-form conversation.
In this Defining Moment, Clinical Nutritionist Sally O’Neil explains why rapid fat loss doesn’t automatically mean better health.
We unpack the rise of GLP-1 weight loss drugs like Ozempic and Mounjaro, how they suppress appetite, and the hidden risks that can follow. From muscle loss and nutrient deficiencies to hair thinning, hormonal disruption and long-term metabolic consequences, Sally explains what can happen when calories drop but food quality does not improve.
We also discuss:
- Why discipline still matters in the Ozempic era
- How low calorie intake can quietly create deficiencies
- The risks of accessing fat loss drugs through grey-market clinics
- Why “skinny” and “healthy” are not the same thing
If this resonates and you want the full context, the complete episode with Sally O’Neil dives deeper into GLP-1 drugs, AI in nutrition, modern diet culture, and what sustainable fat loss actually looks like.
Watch or listen to the full conversation on YouTube, Spotify and Apple Podcasts.
Follow us on Instagram: @defining_moments_pod
SPONSORS:
FREE VIRTUAL ASSUSTANT - Use referral code MOMENTS at www.remotee.com.au/contact to trial a VIRTUAL ASSISTANT with REMOTEE for your business for TWO WEEKS ABSOLUTELY FREE! It's a great way to grow and scale your business today.
10% OFF CHIEF NUTRITION - Use the following link https://www.wearechief.com/CHIEF094681